Skip to content

A study to compare the effectiveness of shigrvadi taila nasal drops and katu taila nasal drops along with nidigdhakavaleha in children with allergic rhinitis

Randomized comparative clinical study on the efficacy of shigruvadi taila pratimarsha nasya and katu taila pratimarsha nasya along with nidigdhakavaleha in vataja pratishyaya w.s.r allergic rhinitis in children - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/04/109268
Enrollment
60
Registered
2026-04-24
Start date
Unknown
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

None listed

Sponsors

Madan Mohan Malviya Government Ayurveda College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children aged between 4 and 16yrs irrespective of sex, religion etc. Children having cardinal features of Allergic Rhinitis. Children whose parents are willing to give consent for the trial.

Exclusion criteria

Exclusion criteria: Children below 4 and above 16 yrs of age. Children suffering from major systemic illness necessitating long term treatment. Children with known case of malignancy, genetic or congenital anomalies. History of hypersensitivity to any of trial drug or their ingredients. Any other nasal anatomical defects

Design outcomes

Primary

MeasureTime frame
1)Improvement in ayurvedic parameters 2)Reduction in absolute eosinophil count Timepoint: At 45th day of the trial

Secondary

MeasureTime frame
To relieve the symptoms of allergic rhinitisTimepoint: The outcome will be evaluated on completion of duration of intervention i.e. 45 days

Countries

India

Contacts

Public ContactProf Ram Kumar

Madan Mohan Malviya Government Ayurved College

drbhamuramkumar@gmail.com8005857838

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: May 1, 2026